The aim of the present study is to discover a bacterial pigment providing protection and prevention of neurological damage and
cancer development, which can have a role as a non-synthetic
food additive in the food industry as well as an active
drug ingredient of anticancer drugs and
pharmaceuticals for neural injury. Within this scope, Serratia marcescens MB703 strain was used to produce
prodigiosin. Characterization of the
prodigiosin was carried out using UV-VIS, and FT-IR. In addition, its inhibitory action on AChE and
antioxidant activities were determined. The cytotoxic, genotoxic and antigenotoxic activities of the
prodigiosin as well as its antiproliferative activities were detected. It was determined that the maximum production of the
prodigiosin (72 mg/L). The
prodigiosin was found to cause no significant difference in its inhibitory effect on AChE. The
prodigiosin was found effective on all
antioxidant parameters tested. The IC50 values of the
prodigiosin on SK-MEL-30 and HT-29 cells were calculated as 70 and 47 μM, respectively. This IC50 values of the
prodigiosin showed no cytotoxic effect on L929 cells.
Prodigiosin did not have genotoxic effect alone and also seem to decrease DNA damage induced by H2O2 in L929 cells. The findings of in vitro experimental studies suggest that using the
prodigiosin pigment as a
drug candidate for
cancer and
neurodegenerative disease therapy is both effective and safe.